Mapping breast cancer therapy with circulating tumor cells: The expert perspective

Circulating tumor cells (CTCs) have emerged as a key prognostic biomarker for breast cancer, with their role becoming more pronounced in metastatic cases. In metastatic breast cancer, having five or more CTCs per 7.5 mL of blood is linked to poorer survival and more aggressive disease, marking it as...

Full description

Saved in:
Bibliographic Details
Main Authors: Lorenzo Gerratana, Caterina Gianni, Eleonora Nicolò, Letizia Pontolillo, Francois-Clement Bidard, Carolina Reduzzi, Massimo Cristofanilli
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625004801
Tags: Add Tag
No Tags, Be the first to tag this record!